Radioimmunoassay Market Size to Exceed $1.93 Billion by 2035

As per the SNS Insider Report titled, Radioimmunoassay Market by Product Type, by Radioisotope, by Application, by End User, and Region, Global Forecast 2026–2035, “The global Radioimmunoassay Market size was valued at USD 1.20 billion in 2025, is anticipated to grow to USD 1.93 billion by 2035, registering a CAGR of 4.89% during the forecast period 2026–2035.”

Key Takeaways

Reagents & Kits accounted for the largest market share of 44.8% in 2025, driven by their extensive use in routine diagnostic testing, hormone analysis, and research applications.
Software emerged as the fastest-growing product type segment and is projected to register a CAGR of 7.9% during 2026–2035 due to increasing laboratory automation and data management requirements.
Iodine-125 dominated the radioisotope segment with a 41.2% revenue share in 2025 owing to its widespread use in highly sensitive immunoassay procedures.
Indium-111 is anticipated to witness the fastest growth at a CAGR of 8.1% through 2035, supported by expanding applications in specialized diagnostic and pharmaceutical research activities.
Endocrinology held the largest application share of 46.5% in 2025 due to the growing prevalence of hormonal disorders and increasing demand for accurate hormone testing.
Drug Testing & Pharmacokinetics is expected to be the fastest-growing application segment, expanding at a CAGR of 7.6% during the forecast period.
Clinical Laboratories accounted for the highest market share of 42.7% in 2025, supported by rising diagnostic testing volumes and increasing adoption of advanced immunoassay technologies.
Pharmaceutical & Biotechnology Companies are projected to witness the fastest CAGR of 7.4% during 2026–2035 due to growing investments in drug development and biomarker research.
North America dominated the Radioimmunoassay Market with approximately 36.00% of total revenue in 2025, while Asia Pacific is expected to register the fastest CAGR of 6.73% through 2035.

Why Radioimmunoassay Market is Growing?

The Radioimmunoassay Market is experiencing continuous growth owing to an increasing demand for advanced diagnostic techniques that are able to detect even the smallest quantities of hormones, proteins, drugs, and other biological substances. The use of radioimmunoassay techniques has been popular for years due to its precision and sensitivity.

An increase in the occurrence of endocrine diseases, cancers, infections, and metabolic disorders has resulted in a higher demand for more sophisticated diagnostic tools in order to diagnose and treat these diseases effectively. Radioimmunoassay techniques are now being used by many healthcare organizations to identify these diseases early and to monitor their progression and treatment.

Research laboratories, pharmaceutical organizations, and biotechnology firms are also driving growth in the radioimmunoassay market through research on new drugs, drug metabolism, and bioactive molecules. Radioimmunoassays are now frequently used by research institutions in evaluating drugs and their biological properties before they are approved for use in patients.

Furthermore, developments in laboratory automation, electronic laboratory notebooks, and digital management systems have been aiding the wider adoption of radioimmunoassays.

Radioimmunoassay Market Statistics

Hormonal disorders such as thyroid diseases, diabetes-related complications, and reproductive health conditions continue to increase globally, supporting demand for endocrine testing solutions.
Pharmaceutical companies are expanding investments in clinical trials and drug development programs that require highly sensitive analytical methods for biomarker quantification.
Growing adoption of precision medicine is increasing the need for accurate diagnostic technologies capable of detecting low-concentration biological markers.
Clinical laboratories worldwide are implementing advanced automation systems to improve workflow efficiency and testing accuracy.
Rising healthcare expenditure across emerging economies is supporting investments in advanced diagnostic infrastructure and laboratory capabilities.
Increasing research activities focused on oncology, immunology, and infectious diseases are creating new opportunities for radioimmunoassay applications.
Technological advancements in assay software and laboratory information management systems are enhancing data accuracy, traceability, and regulatory compliance.

Emerging Trends

There is a lot happening within the Radioimmunoassay Market due to the introduction of advanced software solutions, lab automation techniques, and digital analytics technologies. In an effort to cut down test processing time and improve accuracy, most laboratories have been incorporating lab automation techniques into their work processes.

Also notable is the incorporation of radioimmunoassays in pharmaceutical testing, especially in pharmacokinetic tests, drug monitoring tests, and biomarker development tests. This trend has been accelerated by the rising importance of personalized medicine in the sector.

Furthermore, there have been improvements made to the reagents used, making them stable, specific, and easy to use, thus facilitating the entire process. In addition to all that, there are advancements being made in radioisotope technology to improve efficacy.

Furthermore, the growth in healthcare facilities in Asia Pacific will be very instrumental in fostering market growth in the coming years.

Top 10 Companies